DAAOI-1

Developed for: schizophrenia
Investigated by: China Medical University Hospital · Department of Health, Executive Yuan, R.O.C. (Taiwan)

today NCT01390376 · Ph 2

20112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT01390376	Sep 2010 → Sep 2014	schizophrenia	China Medical University Hospital	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	DAAOI-1	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01390376 ↗
Action	Inhibit	“DAAOI-1, a D-amino acid oxidase (DAAO) inhibitor” NCT01390376 ↗